The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail

Questran 4g/sachet, Powder for oral suspension

CHEPLAPHARM Arzneimittel GmbHPA2239/005/001

Main Information

Trade NameQuestran 4g/sachet, Powder for oral suspension
Active SubstancesColestyramine resin
Dosage FormPowder for oral suspension
Licence HolderCHEPLAPHARM Arzneimittel GmbH
Licence NumberPA2239/005/001

Group Information

ATC CodeC10AC Bile acid sequestrants
C10AC01 colestyramine


License statusAuthorised
Licence Issued01/04/1979
Legal statusProduct subject to prescription which may be renewed (B)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusMarketed


Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available
« Back